{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:23:42Z","timestamp":1761488622086},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jbspin.2010.12.001","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T06:46:47Z","timestamp":1295851607000},"page":"352-357","source":"Crossref","is-referenced-by-count":12,"title":["Role for interferon-gamma release assays in latent tuberculosis screening before TNF-\u03b1 antagonist therapy"],"prefix":"10.1016","volume":"78","author":[{"given":"Huguette","family":"Liot\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.12.001_bib0005","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-TNF agents and tuberculosis risk: mechanism of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0015","first-page":"35","article-title":"Why does TNF-targeted therapy reactivate tuberculosis?","volume":"32","author":"Ehlers","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0020","first-page":"973","article-title":"Immunological protection against tuberculosis","volume":"97","author":"Hanekom","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0025","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0761-8425(08)75089-7","article-title":"Tuberculosis, anti-TNF agents and other immunosuppressants: evolution of preventitive strategies","volume":"25","author":"Liot\u00e9","year":"2008","journal-title":"Rev Mal Resp"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0035","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"BIOBADASER Group: Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0050","first-page":"706","article-title":"Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers","volume":"34","author":"Seong","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.jidsymp.5650031","article-title":"Reactivation of latent tuberculosis by TNF blockade: the role of interferon \u03b3","volume":"12","author":"Wallis","year":"2007","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor antibody therapy than with soluble tumor necrosis factor receptor therapy","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0065","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetimm.2008.10.293","article-title":"Th1-Th2 polarization and autophagy in the control of intracellular mycobacteria by macrophages","volume":"128","author":"Harris","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/ard.61.suppl_2.ii62","article-title":"Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents","volume":"61","author":"Furst","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/keh464","article-title":"Update on the British Society for Rheumatology guidelines for prescribing TNF-\u03b1 blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)","volume":"44","author":"Ledingham","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0085","unstructured":"http:\/\/www.afssaps.sante.fr."},{"key":"10.1016\/j.jbspin.2010.12.001_bib0090","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ibd.20496","article-title":"Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy","volume":"14","author":"Zabana","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0095","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0100","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-007-0591-4","article-title":"Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha","volume":"26","author":"Hanta","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbspin.2009.10.012","article-title":"Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment","volume":"77","author":"Bray","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0110","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ard.2002.004598","article-title":"High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors","volume":"62","author":"Vanhoof","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2007.076406","article-title":"Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic","volume":"67","author":"Mor","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0120","first-page":"1208","article-title":"TNF a-antagonist hepatotoxicity","volume":"75","author":"Larrey","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2036.2007.03553.x","article-title":"Review article: minimizing tuberculosis during anti-TNF-a treatment of inflammatory bowel disease","volume":"27","author":"Theis","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0135","first-page":"1127","article-title":"Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis","volume":"10","author":"Sichletidis","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-147-10-200711200-00006","article-title":"Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab","volume":"147","author":"Raval","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0145","first-page":"543","article-title":"Advantages and drawbacks of in vitro interferon-\u03b3\/T cell assays compared to the Mantoux test for the diagnosis of tuberculosis","volume":"46","author":"Hermann","year":"2006","journal-title":"Rev Fr All Immunol Clin"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0150","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence based comparison of commercial interferon-gamma release assays for detecting active tuberculosis \u2013 a meta-analysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0155","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"TBNET. LTBI: latent tuberculosis infection or lasting immune responses to M.\u00a0tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0160","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment","volume":"27","author":"Bocchino","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0165","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0170","first-page":"1271","article-title":"Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment","volume":"35","author":"Vassilopoulos","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0180","first-page":"1177","article-title":"Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers","volume":"11","author":"Cobanoglu","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0185","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/rheumatology\/kem064","article-title":"Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience","volume":"46","author":"Pratt","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0190","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3899\/jrheum.080854","article-title":"Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy","volume":"36","author":"Behar","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0195","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0200","first-page":"123","article-title":"New tools for a better diagnosis of latent tuberculosis infection","volume":"97","author":"Ferrara","year":"2006","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/kem351","article-title":"Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay","volume":"47","author":"Dinser","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0210","first-page":"770","article-title":"Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis","volume":"35","author":"Greenberg","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0215","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3899\/jrheum.081292","article-title":"Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases","volume":"36","author":"Soborg","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0220","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0225","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","article-title":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","article-title":"Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis","volume":"69","author":"Martin","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0235","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.micinf.2007.02.021","article-title":"CXCL10\/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7","volume":"9","author":"Ruhwald","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0245","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccm.2009.08.016","article-title":"Novel and improved technologies for tuberculosis diagnosis: progress and challenges","volume":"30","author":"Pai","year":"2009","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0250","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00148308","article-title":"T-cell interferon-gamma release assays: can we do better?","volume":"32","author":"Lalvani","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2010.12.001_bib0255","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1371\/journal.pone.0002858","article-title":"Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10","volume":"3","author":"Ruhwald","year":"2008","journal-title":"PLoS One"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10003295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10003295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T02:53:02Z","timestamp":1559962382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1297319X10003295"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.12.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}